TABLE 3.
Delay (n) |
Overall OR (95 % CI)1 |
Delay n (%) |
Common referent OR (95 % CI)1 |
Stratified effects OR (95 % CI)a |
||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Overall | NHW | NHB | NHW | NHB | RERI | |||
| ||||||||
Racial disparity | 1979 | 1537 | – | – | – | 2.15 (1.92–2.41) | ||
Annual patient discharge | ||||||||
Low | 2796 | 1.06 (0.93 to 1.21) | 236 | 484 | 0.73 (0.60 to 0.89) | 2.11 (1.76 to 2.53) | 0.32 (−0.11 to 0.75) | 2.89 (2.25 to 3.70) |
High | 720 | Referent | 1743 | 1053 | Referent | 2.04 (1.79 to 2.33) | Referent | 2.04 (1.79 to 2.33) |
Medical school affiliation | ||||||||
No | 2498 | 0.72 (0.64 to 0.81) | 1541 | 957 | 0.79 (0.67 to 0.93) | 1.70 (1.41 to 2.40) | −0.06 (−0.45 to 0.34) | 2.15 (1.87 to 2.48) |
Yes | 1009 | Referent | 438 | 571 | Referent | 1.94 (1.57 to 2.40) | Referent | 1.94 (1.57 to 2.40) |
Facility type | ||||||||
Government | 309 | 0.40 (0.34 to 0.47) | 120 | 189 | 0.25 (0.20 to 0.32) | 1.20 (0.94 to 1.54) | 0.23 (−0.19 to 0.66) | 4.72 (3.41 to 6.52) |
For-profit | 448 | 0.71 (0.61 to 0.82) | 190 | 258 | 0.54 (0.44 to 0.67) | 1.49 (1.19 to 1.87) | 2.13 (1.87 to 2.40) | 2.72 (2.04 to 3.64) |
Non-profit | 2750 | Referent | 1669 | 1081 | Referent | 1.95 (1.70 to 2.25) | Referent | 1.95 (1.70 to 2.25) |
Accreditations or affiliations | ||||||||
COC-accredited | ||||||||
No | 1423 | 1.24 (1.11 to 1.38) | 643 | 780 | 1.10 (0.95 to 1.27) | 2.28 (1.95 to 2.66) | 0.08 (−0.34 to 0.50) | 2.07 (1.74 to 2.47) |
Yes | 2093 | Referent | 1336 | 757 | Referent | 2.16 (1.85 to 2.52) | Referent | 2.16 (1.85 to 2.52) |
NSABP affiliation | ||||||||
No | 2750 | 0.93 (0.82 to 1.06) | 1675 | 1075 | 0.69 (0.58 to 0.83) | 2.03 (1.69 to 2.43) | 0.33 (−0.8 to 0.74) | 2.92 (2.32 to 3.68) |
Yes | 766 | Referent | 304 | 462 | Referent | 2.01 (1.76 to 2.30) | Referent | 2.01 (1.76 to 2.30) |
Adjusted for age at diagnosis and type of surgery
OR, odds ratio; CI, confidence interval; RERI, relative excess risk due to interaction; NHW, non-Hispanic White; NHB, non-Hispanic Black; COC, commission on cancer; NSABP, National Surgical Adjuvant Breast and Bowel Project